Acumen Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Acumen Pharmaceuticals generated cash of -$43,064,000, which is less than the previous year. Cash used in financing activities reached the amount of $151,753,000 last year. Net change in cash is therefore -$62,982,000.
Cash Flow
| 2019 | -6.81M | 0 | 6.23M |
|---|---|---|---|
| 2020 | -7.45M | 0 | 44.67M |
| 2021 | -17.96M | -104.12M | 200.46M |
| 2022 | -35.15M | 39.18M | 3.90M |
| 2023 | -43.06M | -171.67M | 151.75M |
ABOS Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 130.10M | 122.16M | 43.77M | 6.55M | 7.13M |
Operating activities | |||||
Net income | -52.37M | -42.85M | -100.60M | -7.32M | -7.90M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 184K | 169K | 4K | 0 | 0 |
Stock-based compensation expense | 6.14M | 3.06M | 922K | 154K | 174K |
| Deferred income tax benefit | 6.14M | 3.06M | 922K | 154K | 174K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | -79K | 200K |
Inventories | 0 | 0 | 0 | 79K | -200K |
Accounts payable | -261K | 552K | 557K | 308K | 110K |
Cash generated by operating activities | -43.06M | -35.15M | -17.96M | -7.45M | -6.81M |
Investing activities | |||||
Purchases Of Investments | -250.63M | -41.51M | -104.08M | 0 | 0 |
Investments In Property Plant And Equipment | -21K | -161K | -40K | 0 | 0 |
Acquisitions Net | 0 | -39.34K | 0 | 0 | 0 |
Cash generated by investing activities | -171.67M | 39.18M | -104.12M | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 121.90M | 3.79M | 200.46M | 44.67M | 6.23M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 30M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 151.75M | 3.90M | 200.46M | 44.67M | 6.23M |
Net Change In Cash | -62.98M | 7.93M | 78.38M | 37.22M | -579K |
Cash at end of period | 67.11M | 130.10M | 122.16M | 43.77M | 6.55M |
| Data source | Data source | Data source |